Bausch Health Cos Receivables 2010-2024 | BHC
Bausch Health Cos receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
Bausch Health Cos Annual Receivables
(Millions of US $) |
| 2023 |
$1,998 |
| 2022 |
$1,790 |
| 2021 |
$1,775 |
| 2020 |
$1,577 |
| 2019 |
$1,839 |
| 2018 |
$1,865 |
| 2017 |
$2,130 |
| 2016 |
$2,517 |
| 2015 |
$2,687 |
| 2014 |
$2,076 |
| 2013 |
$1,676 |
| 2012 |
$914 |
| 2011 |
$569 |
| 2010 |
$283 |
| 2009 |
$112 |
Bausch Health Cos Quarterly Receivables
(Millions of US $) |
| 2024-06-30 |
$2,102 |
| 2024-03-31 |
$2,048 |
| 2023-12-31 |
$1,998 |
| 2023-09-30 |
$1,948 |
| 2023-06-30 |
$1,743 |
| 2023-03-31 |
$1,688 |
| 2022-12-31 |
$1,790 |
| 2022-09-30 |
$1,739 |
| 2022-06-30 |
$1,645 |
| 2022-03-31 |
$1,566 |
| 2021-12-31 |
$1,775 |
| 2021-09-30 |
$1,730 |
| 2021-06-30 |
$1,609 |
| 2021-03-31 |
$1,499 |
| 2020-12-31 |
$1,577 |
| 2020-09-30 |
$1,733 |
| 2020-06-30 |
$1,369 |
| 2020-03-31 |
$1,712 |
| 2019-12-31 |
$1,839 |
| 2019-09-30 |
$1,747 |
| 2019-06-30 |
$1,829 |
| 2019-03-31 |
$1,786 |
| 2018-12-31 |
$1,865 |
| 2018-09-30 |
$2,041 |
| 2018-06-30 |
$1,973 |
| 2018-03-31 |
$1,940 |
| 2017-12-31 |
$2,130 |
| 2017-09-30 |
$2,229 |
| 2017-06-30 |
$2,096 |
| 2017-03-31 |
$2,097 |
| 2016-12-31 |
$2,517 |
| 2016-09-30 |
$2,708 |
| 2016-06-30 |
$2,733 |
| 2016-03-31 |
$2,693 |
| 2015-12-31 |
$2,687 |
| 2015-09-30 |
$2,696 |
| 2015-06-30 |
$2,371 |
| 2015-03-31 |
$2,109 |
| 2014-12-31 |
$2,076 |
| 2014-09-30 |
$1,880 |
| 2014-06-30 |
$1,771 |
| 2014-03-31 |
$1,706 |
| 2013-12-31 |
$1,676 |
| 2013-09-30 |
$1,643 |
| 2013-06-30 |
$1,127 |
| 2013-03-31 |
$1,054 |
| 2012-12-31 |
$914 |
| 2012-09-30 |
$805 |
| 2012-06-30 |
$611 |
| 2012-03-31 |
$614 |
| 2011-12-31 |
$569 |
| 2011-09-30 |
$468 |
| 2011-06-30 |
$435 |
| 2011-03-31 |
$483 |
| 2010-12-31 |
$283 |
| 2010-09-30 |
$291 |
| 2010-06-30 |
$114 |
| 2010-03-31 |
$105 |
| 2009-12-31 |
$112 |
| 2009-09-30 |
$99 |
| 2009-06-30 |
$97 |
| 2009-03-31 |
$83 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.956B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
